- Home
- THRD vs SLND Comparison
THRD vs SLND Comparison
Compare THRD & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- SLND
- Stock Information
- Founded
- THRD 2019
- SLND 1900
- Country
- THRD United States
- SLND United States
- Employees
- THRD N/A
- SLND N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- THRD Health Care
- SLND Industrials
- Exchange
- THRD Nasdaq
- SLND Nasdaq
- Market Cap
- THRD 164.2M
- SLND 175.8M
- IPO Year
- THRD 2022
- SLND N/A
- Fundamental
- Price
- THRD $5.14
- SLND $3.18
- Analyst Decision
- THRD Hold
- SLND Strong Buy
- Analyst Count
- THRD 3
- SLND 1
- Target Price
- THRD $5.00
- SLND $5.00
- AVG Volume (30 Days)
- THRD 1.2M
- SLND 29.4K
- Earning Date
- THRD 05-14-2025
- SLND 05-12-2025
- Dividend Yield
- THRD N/A
- SLND N/A
- EPS Growth
- THRD N/A
- SLND N/A
- EPS
- THRD N/A
- SLND N/A
- Revenue
- THRD N/A
- SLND $980,179,000.00
- Revenue This Year
- THRD N/A
- SLND $4.06
- Revenue Next Year
- THRD N/A
- SLND $7.16
- P/E Ratio
- THRD N/A
- SLND N/A
- Revenue Growth
- THRD N/A
- SLND N/A
- 52 Week Low
- THRD $3.18
- SLND $1.85
- 52 Week High
- THRD $16.94
- SLND $5.98
- Technical
- Relative Strength Index (RSI)
- THRD 79.10
- SLND 53.26
- Support Level
- THRD $5.08
- SLND $2.91
- Resistance Level
- THRD $5.20
- SLND $3.27
- Average True Range (ATR)
- THRD 0.11
- SLND 0.19
- MACD
- THRD 0.13
- SLND 0.03
- Stochastic Oscillator
- THRD 96.84
- SLND 80.70
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.